Calibr-Skaggs and Kainomyx Launch Collaboration to Pioneer Novel Malaria Treatments (IMAGE)

Scripps Research Institute

Calibr-Skaggs and Kainomyx Launch Collaboration to Pioneer Novel Malaria Treatments

Caption

The Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc., will collaborate to accelerate the discovery and development of next-generation antimalarial drugs.

Credit

Scripps Research

Usage Restrictions

Can be used with related coverage and with credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.